Skip to main content

Advertisement

SpringerLink
Log in

Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Cell adhesion is a basic count in inter- and intra-cellular communication and plays an important role in tumor progression. This study was conducted to investigate the serum levels of intercellular adhesion molecule (ICAM-1) and E-selectin in patients with advanced stage non-small cell lung cancer (NSCLC) and the relationships with known prognostic parameters and therapy. These serum factors were measured of 57 NSCLC patients pathologically verified before and after chemotherapy in comparison with 24 healthy controls by using ELİSA method. Serum levels of ICAM-1 were increased significantly in NSCLC patients compared with the healthy controls (P = 0.006). However, serum E-selectin levels were not significantly different from healthy control groups (0.643). No statistically significant relationships were found between investigated all serum parameters and various characteristics of patients, and the diseases such as stage and tumor burden. Likewise, we also found no correlation between serum ICAM-1 and E-selectin (P = 0.78). We found that serum ICAM-1 levels were decreased owing to the chemotherapy effect, independently from chemotherapy response. However, serum E-selectin levels were not changed by the chemotherapy effect. The median survival of all patients was 11.9 months and 1-year survival rate was 47.6%. We found that patients performance status (P = 0.013), age (P = 0.015), and weight loss (P = 0.007) were prognostic factors for survival. Serum E-selectin levels showed a trend (P = 0.08) related to worse prognosis, however serum ICAM-1 levels were determined as ineffective on survival (P = 0.11). Multivariate analysis revealed that only weight loss (P = 0.005) and E-selectin levels (P = 0.002) remained as an independent prognostic factor for survival in patients with advanced NSCLC. In conclusion, our data suggest that higher serum ICAM-1 can be useful for diagnosis while E-selectin levels have prognostic significance and could be a potential prognostic factor in NSCLC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Liotta LA, Stracke ML. Tumor invasion and metastases: biochemical mechanisms. Cancer Treat Res 1988;40:223–38.

    PubMed  CAS  Google Scholar 

  2. Pignatelli M, Vessey CJ. Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol 1994;25:849–56.

    Article  PubMed  CAS  Google Scholar 

  3. Williams AF, Barclay AN. The immunoglobulin superfamily—domains for cell surface recognition. Annu Rev Immunol 1988;6:381–405.

    PubMed  CAS  Google Scholar 

  4. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11–25.

    Article  PubMed  CAS  Google Scholar 

  5. Dunon D, Piali L, Imhof BA. To stick or not to stick: the new leukocyte homing paradigm. Curr Opin Cell Biol 1996;8:714–23.

    Article  PubMed  CAS  Google Scholar 

  6. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068–101.

    PubMed  CAS  Google Scholar 

  7. Ozer G, et al. Potential value of soluble intercellular adhesion molecule-1 in the serum of patients with bladder cancer. Urol Int 2003;70:167–71.

    Article  PubMed  CAS  Google Scholar 

  8. Sanchez-Rovira P, et al. Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity. Eur J Cancer 1998;34:394–8.

    Article  PubMed  CAS  Google Scholar 

  9. Alexiou D, et al. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer 2001;37:2392–7.

    Article  PubMed  CAS  Google Scholar 

  10. Banks RE, et al. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993;68:122–4.

    PubMed  CAS  Google Scholar 

  11. Nakata B, et al. Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer. Clin Cancer Res 2000;6:1175–9.

    PubMed  CAS  Google Scholar 

  12. Staal-van den Brekel AJ, Thunnissen FB, Buurman WA, Wouters EF. Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non-small-cell lung carcinoma. Virchows Arch 1996;428:21–7.

    Article  PubMed  CAS  Google Scholar 

  13. Grothey A, Heistermann P, Philippou S, Voigtmann R. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage. Br J Cancer 1998;77:801–7.

    PubMed  CAS  Google Scholar 

  14. Finzel AH, Reininger AJ, Bode PA, Wurzinger LJ. ICAM-1 supports adhesion of human small-cell lung carcinoma to endothelial cells. Clin Exp Metastasis 2004;21:185–9.

    Article  PubMed  CAS  Google Scholar 

  15. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993;91:379–87.

    Article  PubMed  CAS  Google Scholar 

  16. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992;258:964–9.

    Article  PubMed  CAS  Google Scholar 

  17. Dejana E, et al. Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab Invest 1992;66:324–30.

    PubMed  CAS  Google Scholar 

  18. Lauri D, Needham L, Martin-Padura I, Dejana E. Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells. J Natl Cancer Inst 1991;83:1321–4.

    Article  PubMed  CAS  Google Scholar 

  19. Van Duinen CM, Van den Broek LJ, Vermeer BJ, Fleuren GJ, Bruijn JA. The distribution of cellular adhesion molecules in pigmented skin lesions. Cancer 1994;73:2131–9.

    Article  PubMed  Google Scholar 

  20. Groves RW, et al. Expression of selectin ligands by cutaneous squamous cell carcinoma. Am J Pathol 1993;143:1220–5.

    PubMed  CAS  Google Scholar 

  21. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 1997;14:577–84.

    Article  PubMed  CAS  Google Scholar 

  22. Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I. Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 1996;183:581–7.

    Article  PubMed  CAS  Google Scholar 

  23. Velikova G, et al. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer 1998;77:1857–63.

    PubMed  CAS  Google Scholar 

  24. Wittig BM, et al. Elevated serum E-selectin in patients with liver metastases of colorectal cancer. Eur J Cancer 1996;32:1215–8.

    Article  Google Scholar 

  25. Franzke A, et al. Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. Br J Cancer 1998;78:40–5.

    PubMed  CAS  Google Scholar 

  26. Zhang GJ, Adachi I. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis. Int J Oncol 1999;14:71–7.

    PubMed  CAS  Google Scholar 

  27. Dy GK, Adjei AA. Novel targets for lung cancer therapy: part II. J Clin Oncol 2002;20:3016–28.

    Article  PubMed  CAS  Google Scholar 

  28. Aljada IS, et al. Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer. J Clin Oncol 2004;22:3218–29.

    Article  PubMed  CAS  Google Scholar 

  29. Nair KS, Naidoo R, Chetty R. Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol 2005;58:343–51.

    Article  PubMed  CAS  Google Scholar 

  30. Perabo F, et al. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies. Indian J Cancer 2001;38:1–7.

    PubMed  CAS  Google Scholar 

  31. Roselli M, et al. Soluble selectin levels in patients with lung cancer. Int J Biol Markers 2002;17:56–62.

    PubMed  CAS  Google Scholar 

  32. Esposito V, et al. Expression of surface protein receptors in lung cancer. Anticancer Res 2002;22:4039–43.

    PubMed  CAS  Google Scholar 

  33. Schardt C, Heymanns J, Schardt C, Rotsch M, Havemann K. Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types. Eur J Cancer 1993;29:2250–5.

    Article  Google Scholar 

  34. Passlick B, et al. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance. Eur J Cancer 1994;30:376–81.

    Article  Google Scholar 

  35. Shin HS, Jung CH, Park HD, Lee SS. The relationship between the serum intercellular adhesion molecule-1 level and the prognosis of the disease in lung cancer. Korean J Intern Med 2004;19:48–52.

    PubMed  CAS  Google Scholar 

  36. Ruco LP, et al. Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in undifferentiated nasopharyngeal carcinoma (lymphoepithelioma) and in malignant epithelial tumors. Hum Pathol 1994;25:924–8.

    Article  PubMed  CAS  Google Scholar 

  37. Vitolo D, et al. Cytokine production and expression of adhesion molecules and integrins in tumor infiltrating lymphomononuclear cells of non-small cell carcinomas of the lung. Am J Pathol 1994;145:322–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Oncology, Istanbul University, 34390, Istanbul, Turkey

    Nese Guney, Hilal Oguz Soydinc, Duygu Derin, Faruk Tas, Hakan Camlica, Derya Duranyildiz, Vildan Yasasever & Erkan Topuz

Authors
  1. Nese Guney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hilal Oguz Soydinc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Duygu Derin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Faruk Tas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hakan Camlica
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Derya Duranyildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vildan Yasasever
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Erkan Topuz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nese Guney.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guney, N., Soydinc, H.O., Derin, D. et al. Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer. Med Oncol 25, 194–200 (2008). https://doi.org/10.1007/s12032-007-9026-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-007-9026-y

Keywords

Search

Navigation